Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grabowski

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
Cell|June 25, 2011
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathiesJoseph R Mazzulli, You-Hai Xu, Ying Sun, et al.
Journal of Lipid Research|December 3, 2013
Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier functionJorge F Haller, Paul Cavallaro, Nicholas J Hernandez, et al.
BMC Genomics|January 13, 2011
Global gene expression profile progression in Gaucher disease mouse modelsYou-Hai Xu, Li Jia, Brian Quinn, et al.
Molecular Genetics and Metabolism|May 20, 2014
Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency diseaseYing Sun, You-Hai Xu, Hong Du, et al.
Pediatric Research|December 1, 1976
Mannosidosis: clinical, morphologic, immunologic, and biochemical studiesR J Desnick, H L Sharp, G A Grabowski, et al.
BMC Neuroscience|August 5, 2008
Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient miceYing Sun, Li Jia, Michael T Williams, et al.
Molecular Genetics and Metabolism|January 2, 2017
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher RegistryAmal El-Beshlawy, Anna Tylki-Szymanska, Ashok Vellodi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, <i>GBA1</i> mutation-associated pathologies and diseasesXiangli Zhao, Yi Lin, Benjamin Liou, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 18, 2017
Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass SpectrometryE Ellen Jones, Wujuan Zhang, Xueheng Zhao, et al.
Ebiomedicine|February 4, 2018
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher DiseaseJinlong Jian, Yuehong Chen, Rossella Liberti, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Cell|June 25, 2011
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathiesJoseph R Mazzulli, You-Hai Xu, Ying Sun, et al.
Journal of Lipid Research|December 3, 2013
Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier functionJorge F Haller, Paul Cavallaro, Nicholas J Hernandez, et al.
BMC Genomics|January 13, 2011
Global gene expression profile progression in Gaucher disease mouse modelsYou-Hai Xu, Li Jia, Brian Quinn, et al.
Molecular Genetics and Metabolism|May 20, 2014
Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency diseaseYing Sun, You-Hai Xu, Hong Du, et al.
Pediatric Research|December 1, 1976
Mannosidosis: clinical, morphologic, immunologic, and biochemical studiesR J Desnick, H L Sharp, G A Grabowski, et al.
BMC Neuroscience|August 5, 2008
Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient miceYing Sun, Li Jia, Michael T Williams, et al.
Molecular Genetics and Metabolism|January 2, 2017
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher RegistryAmal El-Beshlawy, Anna Tylki-Szymanska, Ashok Vellodi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, <i>GBA1</i> mutation-associated pathologies and diseasesXiangli Zhao, Yi Lin, Benjamin Liou, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 18, 2017
Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass SpectrometryE Ellen Jones, Wujuan Zhang, Xueheng Zhao, et al.
Ebiomedicine|February 4, 2018
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher DiseaseJinlong Jian, Yuehong Chen, Rossella Liberti, et al.
Pageof 26